Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders.
Br J Psychiatry
; 217(1): 351, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-210335
ABSTRACT
Many psychiatric patients have been infected with COVID-19, and patients with COVID-19 may develop psychiatric symptoms after treatment with antiviral drugs. Given the tolerability and minimal P450 interactions, antidepressants (i.e., citalopram, escitalopram etc.), antipsychotics (i.e., olanzapine) and valproate can be considered to be safe in combination with antiviral drugs.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Psychotropic Drugs
/
Coronavirus Infections
/
Drug Interactions
/
Drug Therapy, Combination
/
Pandemics
/
Mental Disorders
Type of study:
Observational study
/
Qualitative research
Limits:
Humans
Language:
English
Journal:
Br J Psychiatry
Year:
2020
Document Type:
Article
Affiliation country:
Bjp.2020.84
Similar
MEDLINE
...
LILACS
LIS